16-89739506-T-C

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_000135.4(FANCA):​c.3982A>G​(p.Thr1328Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0777 in 1,551,258 control chromosomes in the GnomAD database, including 5,562 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1328I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.060 ( 421 hom., cov: 33)
Exomes 𝑓: 0.080 ( 5141 hom. )

Consequence

FANCA
NM_000135.4 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts P:1B:9O:1

Conservation

PhyloP100: -0.994

Publications

31 publications found
Variant links:
Genes affected
FANCA (HGNC:3582): (FA complementation group A) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq, Jul 2008]
ZNF276 (HGNC:23330): (zinc finger protein 276) Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in kinetochore. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 3 benign, 25 uncertain in NM_000135.4
BP4
Computational evidence support a benign effect (MetaRNN=0.007843435).
BP6
Variant 16-89739506-T-C is Benign according to our data. Variant chr16-89739506-T-C is described in ClinVar as Benign. ClinVar VariationId is 134278.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.209 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000135.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FANCA
NM_000135.4
MANE Select
c.3982A>Gp.Thr1328Ala
missense
Exon 40 of 43NP_000126.2
ZNF276
NM_001113525.2
MANE Select
c.*1260T>C
3_prime_UTR
Exon 11 of 11NP_001106997.1
FANCA
NM_001286167.3
c.3982A>Gp.Thr1328Ala
missense
Exon 40 of 43NP_001273096.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FANCA
ENST00000389301.8
TSL:1 MANE Select
c.3982A>Gp.Thr1328Ala
missense
Exon 40 of 43ENSP00000373952.3
ZNF276
ENST00000443381.7
TSL:1 MANE Select
c.*1260T>C
3_prime_UTR
Exon 11 of 11ENSP00000415836.2
ZNF276
ENST00000289816.9
TSL:1
c.*1260T>C
3_prime_UTR
Exon 11 of 11ENSP00000289816.5

Frequencies

GnomAD3 genomes
AF:
0.0596
AC:
9071
AN:
152126
Hom.:
420
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0140
Gnomad AMI
AF:
0.0230
Gnomad AMR
AF:
0.0376
Gnomad ASJ
AF:
0.0580
Gnomad EAS
AF:
0.218
Gnomad SAS
AF:
0.0263
Gnomad FIN
AF:
0.0613
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0833
Gnomad OTH
AF:
0.0569
GnomAD2 exomes
AF:
0.0661
AC:
10322
AN:
156058
AF XY:
0.0661
show subpopulations
Gnomad AFR exome
AF:
0.0139
Gnomad AMR exome
AF:
0.0210
Gnomad ASJ exome
AF:
0.0563
Gnomad EAS exome
AF:
0.238
Gnomad FIN exome
AF:
0.0609
Gnomad NFE exome
AF:
0.0803
Gnomad OTH exome
AF:
0.0568
GnomAD4 exome
AF:
0.0797
AC:
111444
AN:
1399014
Hom.:
5141
Cov.:
34
AF XY:
0.0783
AC XY:
54032
AN XY:
690082
show subpopulations
African (AFR)
AF:
0.0112
AC:
353
AN:
31602
American (AMR)
AF:
0.0226
AC:
807
AN:
35716
Ashkenazi Jewish (ASJ)
AF:
0.0563
AC:
1419
AN:
25184
East Asian (EAS)
AF:
0.153
AC:
5481
AN:
35758
South Asian (SAS)
AF:
0.0222
AC:
1758
AN:
79256
European-Finnish (FIN)
AF:
0.0579
AC:
2835
AN:
48966
Middle Eastern (MID)
AF:
0.0134
AC:
73
AN:
5432
European-Non Finnish (NFE)
AF:
0.0870
AC:
93899
AN:
1079098
Other (OTH)
AF:
0.0831
AC:
4819
AN:
58002
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
6065
12130
18195
24260
30325
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3536
7072
10608
14144
17680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0596
AC:
9078
AN:
152244
Hom.:
421
Cov.:
33
AF XY:
0.0575
AC XY:
4280
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.0139
AC:
579
AN:
41540
American (AMR)
AF:
0.0375
AC:
574
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0580
AC:
201
AN:
3466
East Asian (EAS)
AF:
0.219
AC:
1135
AN:
5178
South Asian (SAS)
AF:
0.0272
AC:
131
AN:
4822
European-Finnish (FIN)
AF:
0.0613
AC:
651
AN:
10622
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0833
AC:
5664
AN:
68004
Other (OTH)
AF:
0.0572
AC:
121
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
452
903
1355
1806
2258
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0782
Hom.:
1148
Bravo
AF:
0.0572
TwinsUK
AF:
0.0984
AC:
365
ALSPAC
AF:
0.0823
AC:
317
ESP6500AA
AF:
0.0136
AC:
57
ESP6500EA
AF:
0.0706
AC:
579
ExAC
AF:
0.0307
AC:
2659
Asia WGS
AF:
0.113
AC:
392
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Pathogenic:1Benign:9Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fanconi anemia complementation group A Pathogenic:1Benign:4
Nov 15, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 23, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Feb 28, 2020
Leiden Open Variation Database
Significance:Pathogenic
Review Status:flagged submission
Collection Method:curation

Curator: Arleen D. Auerbach. Submitter to LOVD: Arleen D. Auerbach.

Jul 10, 2025
GeneKor MSA
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:2Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dec 18, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: FANCA c.3982A>G (p.Thr1328Ala) results in a non-conservative amino acid change in the encoded protein sequence. Two of three in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.066 in 156058 control chromosomes in the gnomAD database, including 617 homozygotes. The observed variant frequency is approximately 30.55 fold of the estimated maximal expected allele frequency for a pathogenic variant in FANCA causing Fanconi Anemia phenotype (0.0022), strongly suggesting that the variant is benign. Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Five classified the variant as benign while one classified as pathogenic. Based on the evidence outlined above, the variant was classified as benign.

not provided Benign:2
Mar 12, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 31586946, 9371798, 27121516)

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Fanconi anemia Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
0.11
DANN
Benign
0.44
DEOGEN2
Benign
0.14
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.35
N
LIST_S2
Benign
0.42
T
MetaRNN
Benign
0.0078
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.83
L
PhyloP100
-0.99
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.85
N
REVEL
Benign
0.20
Sift
Benign
0.44
T
Sift4G
Benign
0.26
T
Polyphen
0.0050
B
Vest4
0.017
ClinPred
0.00030
T
GERP RS
-1.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.031
gMVP
0.10
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9282681; hg19: chr16-89805914; COSMIC: COSV57066209; COSMIC: COSV57066209; API